Fighting cancer with a Patient's own supercharged immune cells
Disease control
Not yet recruiting
This study is testing a new personalized treatment called LM103 TILs to see if it can help prevent lung cancer from coming back after surgery. It is for people with a specific type of non-small cell lung cancer who have already had initial treatment. Researchers will take a patie…
Phase: PHASE2 • Sponsor: Suzhou BlueHorse Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC